Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Effects of IV Hydromorphone and Buprenorphine in Opioid Dependent Pain
NCT02372591Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of buprenorphine extended-release injection in chronic musculoskeletal pain (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Cold Pressor Test Analgesia. Started Aug 2015; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
chronic musculoskeletal pain
Beyond the preview
Go deeper on NCT02372591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372591.